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Abstract
Background: The asexual blood stages of the human malaria parasite Plasmodium falciparum produce highly immunogenic
polymorphic antigens that are expressed on the surface of the host cell. In contrast, few studies have examined the surface
of the gametocyte-infected erythrocyte.
Methodology/Principal Findings: We used flow cytometry to detect antibodies recognising the surface of live cultured
erythrocytes infected with gametocytes of P. falciparum strain 3D7 in the plasma of 200 Gambian children. The majority of
children had been identified as carrying gametocytes after treatment for malaria, and each donated blood for mosquito-
feeding experiments. None of the plasma recognised the surface of erythrocytes infected with developmental stages of
gametocytes (I–IV), but 66 of 194 (34.0%) plasma contained IgG that recognised the surface of erythrocytes infected with
mature (stage V) gametocytes. Thirty-four (17.0%) of 200 plasma tested recognised erythrocytes infected with trophozoites
and schizonts, but there was no association with recognition of the surface of gametocyte-infected erythrocytes (odds ratio
1.08, 95% C.I. 0.434–2.57; P = 0.851). Plasma antibodies with the ability to recognise gametocyte surface antigens (GSA) were
associated with the presence of antibodies that recognise the gamete antigen Pfs 230, but not Pfs48/45. Antibodies
recognising GSA were associated with donors having lower gametocyte densities 4 weeks after antimalarial treatment.
Conclusions/Significance: We provide evidence that GSA are distinct from antigens detected on the surface of asexual 3D7
parasites. Our findings suggest a novel strategy for the development of transmission-blocking vaccines.
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Introduction
Available evidence suggests that there are specific immune
responses to different stages of the malaria parasite life cycle.
Natural human immune responses to malaria recognise extracel-
lular sporozoites and merozoites, which both have surface-exposed
antigens, and are the targets of various vaccines currently under
development [1]. Blood-stage immunity also involves the acqui-
sition of a repertoire of antibodies (IgG) directed against parasite-
encoded variant surface antigens (VSA) on the surface of the
infected erythrocyte [2,3]. Carriage of IgG which recognise VSA,
including P. falciparum erythrocyte membrane protein-1 (PfEMP-1)
[4,5], is associated with protection from clinical malaria [6–11].
Transmissible sexual stages of the malaria parasite, gametocytes,
frequently die in the host without being passed on to a mosquito,
and in doing so release intracellular antigens into the host
circulation. Among these antigens are a number that elicit
humoral responses which mediate transmission blocking immuni-
ty. This occurs when human antibodies, taken up by a mosquito in
a potentially infective blood-meal containing male and female
Plasmodium gametocytes, are able to block further parasite
development and prevent infection of the mosquito. This
immunity is known to be antibody-mediated [12] and is directed
against the parasites in the mid-gut of the mosquitoes immediately
after ingestion of a blood meal by the mosquito [13–17]. Targets
of this immunity include the gamete surface proteins Pfs230 and
Pfs48/45, but other antigens may be involved. These gamete
proteins are not present on the surface of intact gametocytes and
thus antibodies against these antigens are unlikley to have any
effect on the parasite in the human host.
By comparison, little is known about any specific immune
responses that may recognise the surface of erythrocytes infected
with sexual stages of malaria parasites during their development in
the human body. We know that erythrocytes infected with early
forms of P. falciparum gametocytes sequester away from the
peripheral circulation until they reach maturity [18], which
suggests the presence of adhesins on the gametocyte-infected
erythrocyte surface. Analysis of the adhesion phenotype of stage I–
V gametocytes that mediates binding to C32 melanoma cells [19]
and transformed human bone marrow endothelial cells trHBMEC
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[20] suggests adhesion of sexual stages has some characteristics in
common with, and others that differ from, asexual parasite
adhesion. Further, the evidence that asexual and sexual stage
parasites sequester in different tissues [20,21] suggests that distinct
antigens exist on the surface of gametocyte-infected erythrocytes
(gametocyte surface antigens, GSA). Such adhesins could conceiv-
ably be either parasite-encoded molecules, altered host membrane
components, or both. We reasoned that such antigens may elicit
specific immune responses, independent of responses to asexual
parasites, which may be capable of suppressing or killing
gametocytes. No studies to date have demonstrated the presence
of GSA. If the surface of gametocyte-infected erythrocytes do elicit
immune responses, then a comparison of these to responses
elicited by asexual parasites and to transmission-blocking antibod-
ies would be of great interest.
We present the results of experiments in which plasma collected
from 200 Gambian children carrying microscopically confirmed
gametocytes 7 to 14 days after treatment for uncomplicated P.
falciparum malaria, were presented with live, cultured P. falciparum
gametocytes. The degree of recognition of each test plasma was
measured by flow cytometry. We demonstrate for the first time the
existence of antibodies which specifically recognise the surface of
gametocyte-infected erythrocytes, and explore associations with
recognition of asexual parasites and gamete antigens Pfs 48/45
and Pfs 230.
Methods and Materials
Patients and plasma samples
During the months of October to December 2000, 2001 &
2002, children under 10 years presenting as outpatients to
Farafenni hospital, The Gambia, were recruited into clinical trials
to study the effects of antimalarial treatment on P. falciparum
transmission (N=536, 500 and 497 in 2000, 2001 and 2002
respectively; refs 22–25). All participants or their parents/
guardians gave informed consent to participation in these studies
as previously described. Children were treated with chloroquine
(CQ), sulphadoxine-pyrimethamine (SP), CQ/SP in combination,
CQ combined with artesunate (CQ/AS) or artemether-lumefan-
trine (AL).
Seventy, 72 and 27 children in each year respectively were
identified as gametocyte carriers 7 days after treatment and
donated venous blood for membrane-feeding of Anopheles mosqui-
toes as previously described [23–26]. In 2002, an additional 35
patients, randomly selected from among those without gameto-
cytes 7 days after treatment, donated blood for membrane-feeding
of mosquitoes, giving a total of 204 experiments. Each blood
sample was collected in the anti-coagulant citrate phosphate
dextrose, and the plasma separated from cells by centrifugation.
200 plasma samples were available for the current analysis.
Specific additional permission for the use of these plasma samples
in the experiments described was obtained from the Joint Gambia
Government/MRC Ethics Committee.
Negative controls for flow cytometry experiments were seven
individual sera from UK resident adults who had never been to a
malaria endemic area, obtained from whole blood by removal of
coagulated cellular material. Each of these donors provided
written, informed consent under a protocol approved by the
LSHTM Ethics Committee. A pool of these seven negative sera,
and three other independent pools of sera from the same source of
non-malaria exposed European donors were also used. The serum
of an immune Dutch adult whose transmission blocking immunity
had been previously assessed as high level using the standardised
membrane feeding assay [27] was kindly provided by Teun
Bousema, St Radboud University Medical Centre, Nijmegen. This
sample was collected more than 10 years prior to the study from
an individual who gave verbal, but not written, informed consent
to St Radboud UMC for his blood sample to be used for malaria
research.
Definition of transmission blocking from direct
membrane-feeding assay (DMFA)
In the DMFA, blood samples were centrifuged, plasma removed
and the cells washed as described previously [23,26]. Cells,
including gametocyte-infected erythrocytes, were then resus-
pended either back in the autologous plasma (AP) sample itself
or in control serum (CS) from European donors. This serum had
been tested and shown to be permissive for gametocyte survival in
in vitro cultures. The two parallel preparations of gametocytes were
each presented to a cage of approximately 50 adult mosquitoes.
Plasma from the Gambian children donating blood for DMFA
experiments was classified as having transmission-blocking activity
if either of the following two tests were satisfied:
1) transmission occurred among mosquitoes fed with gameto-
cytes in both AP and CS, and the ratio of arithmetic mean
oocyst density was significantly higher in the CS cage than in
the AP cage [23,24].
2) transmission occurred only among mosquitoes fed on
gametocytes presented in CS, and
i. the proportion of infected mosquitoes in the CS-fed cage
was significantly greater than zero by Fisher’s exact test, or
ii. The proportion of infected mosquitoes in the CS-fed
cage was not significantly greater than 0, but at least one
mosquito was heavily infected (.=4 oocysts) in CS and
at least 13 uninfected mosquitoes from the AP-fed cage
were dissected, or
iii. The proportion of infected mosquitoes in the CS-fed cage
was not significantly greater than 0, but at least two
mosquitoes were infected in CS and at least 13 uninfected
mosquitoes from the AP-fed cage were dissected.
Transmission-blocking immunity could not be evaluated in
those DMFA experiments in which there were no infected
mosquitoes in either cage. A heavy infection was defined as at
least 4 oocysts (median of 536 positives among 5000 CS-fed
mosquitoes 1998–2002). Thirteen mosquitoes is used as the cut-off
because it encompasses the majority of our experiments. The
prevalence of infection among 5000 AP-fed insects was 6.5%, and
so on average 0.85 out of 13 AP-fed mosquitoes were infected.
Parasite Culture and Purification
Asexual blood stage parasites were cultured in human type O
negative blood and RPMI 1640 (supplemented with 5.96 g l21
HEPES, 2 gL21 sodium bicarbonate, 50 mg l21 hypoxanthine,
3.96 g l21 glucose and 10% blood type AB serum) and incubated
at 37uC in 3% CO2/1% O2/96% N2 according to established
protocols [28]. Magnet-activated cell sorting (MACS; Miltenyi
BioTec, Bergisch Gladbach, Germany) was used to synchronise
asexual parasite cultures as follows: at ,10% mixed stage
parasitaemia, the culture was washed three times in PBS
supplemented with 2% bovine serum albumin (BSA). The culture
was applied to the MACS apparatus using a CS Column mounted
with a 21G flow resistor, and washed three times with PBS. Flow-
through and washes were subsequently re-applied to the column
once. Erythrocytes containing parasites in late developmental
Gametocyte Surface Antigens
PLoS ONE | www.plosone.org 2 May 2008 | Volume 3 | Issue 5 | e2280
stages, and thus with a high content of paramagnetic hemozoin,
were retained in the column [29], while non-magnetic early-stage
parasites passed through and were collected, washed in PBS/2%
BSA, centrifuged at 500g for 5 minutes at 25uC and put back into
culture with 40 ml/50 ml medium of gentamycin (Gibco, UK).
These synchronsied cultures were left to grow for ,6 hours to
ensure viability before gametocyte cultures were established from
them.
Purification of mature gametocytes
Gametocytes were produced as described elsewhere [30,31]
with the following modifications. A magnet-synchronised asexual
culture at approximately 6% parasitaemia was used to start 15 ml
cultures at a 0.6% parasitaemia and 6% haematocrit. Medium was
changed every day until parasitaemia reached 15–20% at
approximately day 5, and medium was added to a volume of
25 ml, and thus a haematocrit of 3.6%. N-acetyl glucosamine
(NAG) was added at a concentration of 50 mM to kill asexual
stages at approximately day 8 [32–34] and maintained at this
concentration throughout the period of gametocyte culture. Fully
mature gametocytes were harvested 17 days after initiation of the
asexual culture, and purified by magnetic separation through a
MACS column as described previously [35]. Gametocyte maturity
was checked by successfully inducing ex-flagellation as described
elsewhere [30,36]. Earlier stages of gametocyte development were
synchronized and purified as previously described [37].
Flow cytometry
The presence of antibodies in plasma recognizing surface
antigens on parasite-infected RBCs at different stages of
development was demonstrated using an adaptation of a
previously established flow cytometry protocol for asexual
parasites [35]. In brief, cultures were magnet-enriched and
labelled with the nuclear stain ethidium bromide (EB) at 0.1mg/
ml per 105 erythrocytes, differentiating infected (nucleated) from
non-infected (anucleate) erythrocytes. Aliquots (100 ml) of live,
stage-enriched parasite-infected RBCs were incubated for 30 min
each with test plasma (5 ml), goat anti-human plasma (diluted
1:2000) and fluorescein isothiocyanate (FITC)-conjugated rabbit
anti-goat immunoglobulin (diluted 1:25). Samples were washed 3
times between incubations in phosphate buffered saline supple-
mented with 2% foetal calf serum and kept overnight at 4u C
before flow cytometry analysis (FACS Scan, Becton Dickinson).
Before each experiment with each of the parasite stages,
compensation to exclude background flourescence on the vertical
and horizontal axes was carried out on samples single-labelled with
EB or FITC, respectively. For gametocyte stages, plasma samples
from all 200 Gambian children were tested at the same time,
together with control sera. To check that erythrocytes had not
ruptured and thus released free gametes, representative samples
were examined after flow cytometry to confirm that erythrocyte
rupture had not occurred. In addition, side-scatter measurements
indicated that host cells remained intact in our flow cytometry
experiments. Asexual parasites were tested in 3 separate
experiments, with plasma samples batched by year of collection.
Data were analyzed using WinMDI software. EB-positive parasite-
infected erythrocytes were gated and used to create a 2-
dimensional dot blot for each individual sample. Antibody binding
was estimated in terms of the percentage cells labelled with both
EB and FITC, read in the right upper quadrant (RUQ) of the dot
plot. All results shown were confirmed in at least two experiments
with the same reagents, but using independent gametocyte
preparations. Data analysed are from one of those experiments.
We defined a simple cut-off for positivity. For mature
gametocytes, all 200 plasma were run in a single experiment with
negative controls in parallel. The mean proportion of events in the
RUQ quadrant among the six negative control (unexposed
European) plasma was 0.20, with a standard deviation of
0.0305. Plasma were defined as anti-GSA positive sera if with
mature gametocytes the proportion of events in the RUQ was
above a value of 0.261 (i.e. 26.1% of gametocytes being bound by
IgG), representing the mean of the negative controls plus two 2
SD. For asexual parasites, plasma were tested in separate
experiments for each year of collection, with negative controls
run in each experiment. Mean proportion RUQ for asexual
recognition was 0.134, 0.129 and 0.207 for the six negative
controls in experiments testing plasma from 2000, 2001 and 2002
respectively. Positivity was then assigned as for gametocytes using
the relevant mean plus two SD as cut-off, calculated separately for
each of these three experiments.
Immunofluorescence antibody visualisation of immature
gametocytes
Aliquots of early stage gametocytes from the starter flask for
subsequent experiments were acetone-fixed on glass slides and
stored at 220C. Parasites were counter-stained with ethidium
bromide and the incubated with rabbit polyclonal sera recognising
Pfs16 (kind gift of David Baker), washed, and incubated with goat
anti-rabbit IgG (H _ L), conjugated to AlexaFluor 488 (Cambridge
Biosciences). Immunofluorescence was then visualised by confocal
microscopy as previously described [34].
ELISA for antibodies to Pfs48/45 and Pfs 230
The presence of human antibodies of the IgG1 isotype specific
for Pfs230 and Pfs48/45 was determined as previously described
[38]. Positive and negative controls were included on each plate. A
relative recognition ratio was estimated for each plasma for each of
the two sexual stage antigens Pfs48/45 & Pfs230 thus: (OD in the
ELISA test well–OD in control (no primary antibodies) well)/OD
in control well. This was analysed as a continuous variable.
Data analysis
Statistical analysis was performed using Stata (SataCorp. Stata
Statistical Software: Release 8.0, Collage Station, TX: Stata
Corporation). Normally distributed continuous variables were
compared between categories by Student’s t-test; gametocyte
densities and oocyst densities were analysed by comparing the
ratio of arithmetic means in negative binomial regression as
previously described [23,24]. The x2 (chi) test was used to compare
proportions, except where expected values in the 262 tables were
,6, in which case Fisher’s exact test was used.
Results
Purity of synchronous gametocyte cultures
Immunofluorescence experiments were performed to verify that
asexual parasites had been eliminated from the starting gameto-
cyte culture at day 8, as stage I gametocytes are difficult to
discriminate from early trophozoites of the asexual lineage [39].
The majority of ethidium-bromide stained, and therefore
nucleated, erythrocytes examined were found to be positively
stained with anti-Pfs16 antibody (Fig. 1a). Asexual parasites were
estimated to account for fewer than 1% of parasitised cells at this
stage. The culture flasks established from these putative gameto-
cyte cultures were examined 2 days later and found to harbour
well-synchronised gametocytes at stage IIb (Fig. 1b).
Gametocyte Surface Antigens
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Recognition of gametocyte-infected erythrocytes by
plasma antibodies
Serum from a Dutch adult individual, previously established to
have transmission blocking immunity against P. falciparum, was
incubated with a culture of mature asexual stages of P. falciparum
3D7a (late stage trophozoites and schizonts) and the proportion of
ethidium-bromide positive cells that were recognized by antibodies
present in the serum were counted, using flow cytometry. We then
performed similar analyses on 4 sequential stages of gametocyte
development, each derived from the culture shown in Figure 1.
The serum from this individual did not recognize erythrocytes
infected with asexual stages, nor those infected with any of the
immature gametocyte stages. However, this serum strongly
recognised the surface of erythrocytes infected with mature stage
V gametocytes (Fig. 2), suggesting the presence of GSA in the form
of parasite-encoded molecules, altered host membrane compo-
nents, or both on the surface of these cells.
We then tested plasma from 200 Gambian children, to
investigate further the kinetics and nature of development of the
antibodies to surface antigens on RBCs infected with asexual
parasites, with developing sexual stages, or with mature gameto-
cytes of P. falciparum. These children donated blood for membrane
feeding experiments (DMFA) 7, 10 or 14 days after treatment as
previously described [23–25]. The mean age of the children was
5.0 years (95% C.I. 4.71–5.38), and 49 of them (24.4%) had
carried gametocytes at presentation prior to treatment (day 0).
Transmission blocking activity was assessed for each of the plasma
using results from the DMFA. Mosquito infections occurred in 71
of the 199 experiments in which mosquitoes survived until
dissection, 62 of these experiments generated interpretable data
in both cages due to adequate mosquito survival and in 18 of these
(29.0%) there was evidence of transmission-blocking activity by
one of the criteria given in Materials and Methods.
There was no recognition of any immature (stage I–IV) 3D7
gametocytes among the 194 plasma for which data were obtained
(not shown). Sixty-six (34.0%) of these plasma recognized GSA on
the surface of RBCs infected with mature stage V gametocytes, with
a mean proportion of 39.5% of cells in the RUQ (inter-quartile
range 33.0 to 44.6% ; positivity cut-off was 26.1%). Examination of
material after flow cytometry confirmed that gametocytes remained
Figure 1. Purification of early gametocyte stages from cultures
of 3D7a parasites. The top panel shows stage I gametocytes stained
with ethidium bromide (blue) and the sexual parasite-specific anti-Pfs16
antibody (green). The majority of nucleated erythrocytes are also Pfs16
positive and therefore gametocytes. The lower panel shows a Giemsa–
stained thin film of the same culture 2 days later, when all parasites
have reached Stage IIb of gametocyte development. Asexual parasite
contamination was estimated at less than 1%.
doi:10.1371/journal.pone.0002280.g001
Figure 2. Serum antibodies recognise the surface of mature gametocyte-infected RBCs. Serum from a Dutch individual with previously
demonstrated transmission-blocking antibodies was incubated with mature asexual parasites or stage V gametocytes and analysed by flow
cytometry. Parasites were dual labeled with FITC conjugate, indirectly recognising human IgG, and EB staining nuclear DNA. Axes denote the number
of number of cells counted (events) in each dimension.
doi:10.1371/journal.pone.0002280.g002
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inside intact host erythrocytes, and no appreciable gamete release
had occurred during these experiments.
Fifty-three (26.4%) of the 200 plasma successfully tested
recognised the surface of erythrocytes infected with asexual
parasites. Eleven test sera recognized both GSA and the surface
of asexual-infected erythrocytes, but there was no association
between these two reactivities. The relationship between recogni-
tion of sexual and asexual parasites is shown for each plasma in
Figure 3 and Table 1. This suggests these two parasite life cycle
stages place distinct antigen sets on the host erythrocyte surface.
Further, anti-GSA antibodies were more common among older
children (mean age difference 0.621 years, 95% C.I. 0.041–
1.283 years; P= 0.066), but this was not true of antibodies against
the 3D7 asexual parasite surface (mean age difference 0.349 years,
95% C.I. 20.516–1.22 years; P = 0.787).
Surprisingly, day 7, 10 or 14 plasma antibodies that recognised
GSA were less common among children that had harboured
gametocytes prior to treatment, although this was not statistically
significant (Table 1). Children with plasma antibodies that
recognised GSA in the flow cytometry assay were no more likely
to exhibit transmission-blocking activity in the DMFA than other
children. However, transmission blocking activity was significantly
more common among children with antibodies recognising
asexual parasites (Table 1), suggesting this may be related to
either the longevity of infection, or the parasite load, but we did
not have sufficient data from the DMFA to distinguish these
possibilities. Mild anaemia, which is an indicator of a malaria
infection of long duration, was unrelated to the presence of
antibodies recognising either GSA or the surface of asexual
parasites (data not shown).
To further test whether the development of anti-GSA and anti-
asexual antibodies depended on duration of infection, we compared
the prevalence of antibodies in plasma taken at day 7 (N=176) and
at days 10 or 14 (N=21). GSA antibodies were found in 11 of 20
samples from day 10 or 14 that were tested (55.0%) and only among
55 of 171 samples taken at day 7 (32.2%; O.R. 2.58, 95% C.I.
0.907–7.45; P= 0.042). Antibodies recognising asexual parasites did
not occur in any of the plasma samples taken at day 10 or 14, but
were present in 31 of 174 samples taken at day 7 (17.8%). Thus
antibody reactivities to GSA, but not the surface of 3D7 asexual
parasites, were more common in plasma taken 10 days or more after
treatment than they were in day 7 plasma.
Antibodies to GSA and recognition of gamete antigens
Pfs48/45 and Pfs 230
Gamete antigen ELISA assays were conducted for each of 65
plasma collected in 2000. The relative Pfs48/45 and Pfs230
recognition score of each was tested for association with transmis-
sion-blocking immunity as measured by DMFA, and with the ability
to recognise both GSA and the surface of asexual parasites. Results
of these analyses are presented in Table 2. Plasma samples with
antibodies that recognised gametocytes, and those that recognised
asexual parasites exhibited significantly stronger recognition of
Pfs230 (but not Pfs48/45) in ELISA. The same was true of plasma
with demonstrable transmission-blocking activity.
Antibodies to GSA and persisting carriage of
gametocytes
To explore the possibility that antibodies detected in the day 7
plasma of children carrying gametocytes may have affected
gametocyte survival in those hosts, we examined subsequent
gametocyte carriage in children with and without plasma
antibodies to GSA. Children carrying anti-GSA plasma antibodies
at the day blood was donated for DMFA were found to have a
lower mean gametocyte density at day 28, but this was affected by
the treatment received. Among children followed up to day 28 and
receiving non-artemisinin treatments (CQ, SP or CQ/SP; N= 99),
Figure 3. Recognition profiles of plasma IgG from 202 Gambian
children. Erythrocytes harbouring P. falciparum clone 3D7a stage V
gametocytes (left column) and asexual parasite stages (right) were
tested with each of 194 plasma (rows). Plasma are arranged in
increasing order of the proportion of gametocyte recognition events in
the right upper quadrant of the flow cytometry dot-blot. Positive
antibody recognition is scored as dark grey. Pale fill indicates that
antibodies could not be detected above the level of controls (see text).
doi:10.1371/journal.pone.0002280.g003
Table 1. Associations between recognition of asexual- and sexual-stage parasites in flow cytometry, carriage of gametocytes at
presentation and transmission-blocking immunity on plasma from 200 treated Gambian children.
Odds Ratio, (95% C.I.) Antibodies to Mature gametocytes Stage V Antibodies to Mature Asexual Stages
Antibodies to Asexual stages 1.14, (0.454–2.73) P = 0.756 ,
Gametocyte carriage at presentation 0.531, (0.225–1.18) P = 0.098 1.38, (0.513–3.44) P = 0.461
Transmission blocking immunity * 1.59, (0.398–5.89) P = 0.435 5.85, (1.28–27.4) P=0.010
*Only data from feeding experiments with at least one positive mosquito are included (N= 71).
doi:10.1371/journal.pone.0002280.t001
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the presence of anti-GSA plasma IgG was associated with
significantly lower gametocyte densities at day 28 (ratio of means
0.139, 95% C.I. 0.037–0.526; P= 0.004). This was not seen
among the 67 children contributing to this analysis who received
CQ/AS or AL (ratio of means 0.643, 95% C.I. 0.008–50.5;
P = 0.84). Thus, in our studies at least, artemisinin treatment is a
more important determinant of gametocyte persistence than the
presence of anti-GSA antibodies. Gametocyte densities at day 28
were significantly higher among children receiving CQ, SP or
CQ/SP with anti-asexual parasite antibodies present in the blood
sample donated for DMFA (ratio of means 29.7 , 95% C.I. 5.08–
174; P ,0.001; N=101), whereas this was not the case in children
treated with ACT.
Discussion
In this study of malaria patients identified as gametocyte carriers,
we have demonstrated that erythrocytes infected with mature
gametocytes of P. falciparum carry surface antigens that are recognised
by naturally-elicited antibody responses. Our results provide four
lines of evidence that these GSA are distinct from surface antigens
expressed by the asexual stages of cultured 3D7 parasites. Firstly,
serum from a Dutch adult with a previously demonstrated high titre
of transmission-blocking antibodies (T. Bousema, P. Schneider and
R. Sauerwein, personal communication) strongly recognised the
surface of erythrocytes infected with stage V gametocytes, but did not
recognise the surface of erythrocytes infected with 3D7 asexual
parasites (Fig. 2). Secondly, among the 200 plasma from Gambian
donor children, carriage of IgG that recognised GSA was not
associated with recognition of the surface of erythrocytes harbouring
3D7 asexual parasites. Thirdly, anti-GSA antibodies were signifi-
cantly more common in plasma samples taken on days 10 or 14 after
treatment, compared to day 7 plasma, whereas anti-asexual parasite
antibodies were found only in day 7 samples. Finally, among
children treated with non-artemisinin therapy, the presence of anti-
GSA antibodies in day 7, 10 or 14 plasma was significantly
associated with lower gametocyte densities at day 28, whereas anti-
asexual parasite antibodies were associated with significantly higher
gametocyte densities at day 28.
These observations need to be interpreted in the light of the
unique dynamics of gametocyte emergence in P. falciparum
infections, where in successfully treated individuals there is a
delayed peak of peripheral gametocytaemia approximately 7 days
after clearance of asexual parasites[40], whereas the infectiousness
of circulating gametocytes to mosquitoes is highest at 10–14 days
[25]. Where patent or sub-patent persistence of asexual parasites
occurs, gametocyte carriage is significantly extended [41], and
therefore the length of time an individual is exposed to viable
circulating gametocytes, and thus likely to acquire antibodies
recognising GSA, will differ according to treatment outcome, and
to the intrinsic anti-gametocyte effects of the treatment received.
Plasma antibodies that block transmission of P. falciparum and P.
vivax to mosquitoes were first described several decades ago, and
are currently of interest for the development of transmission-
blocking vaccines that target gamete antigens [42]. We measured
transmission-blocking activity in our series of Gambian blood
donors by DMFA [23], and found no association with recognition
of GSA. However, the DMFA has several drawbacks for
identification of transmission-blocking activity compared to the
standardised membrane feeding assay, SMFA, [27], most notably
that blood-fed mosquito cages in which no transmission occur are
not informative. Therefore it would be useful to have our panel of
plasma also tested in the SMFA.
One of the unexpected findings of our study is that none of the
sera or plasma tested recognised the surface of erythrocytes
harbouring immature stages of 3D7 gametocytes. Serum antibod-
ies from a Dutch adult with known transmission-blocking
immunity were found to recognise the surface of erythrocytes
infected with Stage V gametocytes that were demonstrably
competent for exflagellation , but not of those infected with
immature developing gametocytes. Similarly, none of the
Gambian plasma recognised immature gametocytes. Therefore it
appears that the GSA recognised by the antibodies we have
described are distinct from the putative ligands responsible for
sequestration of immature gametocytes during their development
[20,34]. Possible explanations for this apparent contradiction
include, firstly, that the adhesins of immature gametocytes are
highly polymorphic and strain-specific, and those of clone 3D7
were not recognised by immune sera from The Gambia. Secondly,
it may be that gametocyte adhesins are cryptic or non-
immunogenic molecules, or there is a deficiency in the 3D7 clone
that prevents the normal expression of gametocyte adhesins in vitro.
Finally it remains possible that sequestration of immature
gametocytes in vivo does not require the expression of adhesins
on the erythrocyte surface. Experiments with gametocytes derived
from parasites from a variety of genetic backgrounds are needed to
test these possibilities, and to determine whether our observations
made with the 3D7 clone are generally applicable.
The identity of the GSA we have described remains unknown,
and we cannot dismiss the possibility that altered host membrane
proteins are targets of the recognition we have observed. There is
an association between parasite-encoded STEVOR proteins and
the erythrocyte membrane in late stage cultured gametocytes of
the 3D7 line [34], and a subset of these, or of the related rifin
Table 2. Associations between relative recognition of Pfs48/45 sand Pfs230 antigens, and the presence of antibodies against
either GSA or asexual parasite surface antigens, carriage of gametocytes at presentation and transmission-blocking immunity in 65
plasma from Gambian children.
Mean difference in relative recognition (95% CI)* Antibodies to Pfs48/45 Antibodies to Pfs230
Antibodies to Mature gametocytes (Stage V) 0.533 (20.780–1.85) P = 0.420 1.47 (0.429–2.51) P=0.006
Antibodies to Asexual stages 0.875 (20.059–1.81) P = 0.066 1.18 (0.433–1.93) P=0.003
Gametocyte carriage at presentation 0.740 (20.171–1.65) P = 0.110 0.754 (20.006–1.51) P=0.052
Transmission blocking activity ** 0.56 (20.757–1.88) P = 0.393 1.47 (0.364–2.58) P=0.011
*Relative recognition is a ratio, and has no units (see Materials & Methods); mean difference can be positive or negative. If the 95% CI is wholly positive, then the patient
plasma indicated had a significantly higher mean fluorescence in the ELISA, whereas a wholly negative 95% CI would indicate significantly lower mean fluorescence in
the ELISA. P value from 2-sided t-test of Student.
**Data from samples collected in 2000 and infecting at least one mosquito are included (N= 35; see Table 1).
doi:10.1371/journal.pone.0002280.t002
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family may be recognised by anti-GSA antibodies. Other possible
protein targets of anti-GSA antibodies include members of the
PfEMP1 family, as a subset of var genes are known to be
transcribed in gametocytes [37], and the LCCL-domain protein
pSLAP, which is associated with the plasma membrane of
erythrocytes infected with late stage P. falciparum gametocytes
[43]. Future work will employ recombinant forms of candidate
GSA, and specific antibodies raised against these reagents, to
identify the key molecules involved in this natural immune
response to the transmissible form of P. falciparum.
The identity of the antigens recognised on the surface of
erythrocytes infected with asexual parasites in our experiments is
also unclear. In the absence of phenotypic selection using anti-
VSA antibodies or adhesion panning, 3D7 cultures express a
surface phenotype characterised by relatively low level CD36-
dependent endothelial adhesion, and these parasites are poorly
recognised by plasma antibodies from semi-immune children [44].
This explains the lack of association between the age of our plasma
donors and recognition of the surface of erythrocytes infected with
asexual parasites. Therefore it is possible that asexual parasites
with a surface antigen phenotype dominated by the highly
recognised Type A var genes, such as the antibody-selcted 3D7-
Dodowa1 line [11], may have been more commonly recognised by
plasma antibodies from children who recognised GSA. What we
can say with confidence is that mature 3D7 gametocytes in our
synchronised cultures expressed molecules on the host erythrocyte
surface that were not found on erythrocytes harbouring 3D7
asexual parasites from the same cultures.
A subset of our test plasma (those collected in 2000) were
analysed for recognition of recombinant forms of the gamete
antigens Pfs48/45 and Pfs230. Recognition of the latter, but not
the former, was significantly associated with antibodies recognising
both GSA and asexual antigens in the flow cytometry assay, and
with transmission-blocking activity in the DFMA. This is partially
consistent with previous work, which has shown an association
between the presence of antibodies recognising these two gamete
antigens with transmission-blocking activity in the SMFA [14,15].
In most studies, prevalence of antibodies to Pfs230 increases with
age and exposure [38], but it is unknown whether acquisition of
antibodies to GSA may follow a similar pattern.
An exploratory analysis suggests that the presence of anti-GSA
antibodies 1 to 2 weeks after treatment of clinical malaria with non-
ACT regimens are associated with lower gametocyte densities
4 weeks after treatment. Interestingly, anti-asexual parasite antibod-
ies were associated with higher day 28 gametocyte densities in this
same group of treated children, suggesting that in these individuals
sub-patent asexual parasitaemia may be persisting, giving rise to both
antibody responses and subsequent gametocytaemia [41]. The role
of anti-GSA antibodies in controlling gametocytaemia in vivo needs to
be further investigated in longitudinal studies of gametocyte carriage,
but it does appear from results presented here that such an effect may
only be significant in the absence of ACT treatment. Further
longitudinal studies and cross-sectional serological surveys of anti-
GSA antibodies in children with and without gametocytaemia are
needed to further test the association between these antibodies and
gametocyte carriage.
Our results present the first, albeit partial, picture of the
immune response to GSA. The antibodies that recognise GSA are
more common in older children, and are distinct from immune
responses directed against asexual parasite surface antigens in our
unselected cultures. Further, parasitological follow-up data suggest
anti-GSA antibodies are associated with ability to control
gametocyte densities in vivo. We propose that the generation of
vaccine-elicited immunity targeting GSA may represent a feasible
new strategy aimed at blocking the transmission of P. falciparum in
endemic settings, and thus further epidemiological and biological
studies of anti-GSA responses are needed.
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